Phase I safety and pharmacodynamic of inecalcitol, a novel VDR agonist with docetaxel in metastatic castration-resistant prostate cancer patients (Q42704868)
Jump to navigation
Jump to search
scientific article published on 10 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I safety and pharmacodynamic of inecalcitol, a novel VDR agonist with docetaxel in metastatic castration-resistant prostate cancer patients |
scientific article published on 10 July 2014 |
Statements
1 reference
Phase I safety and pharmacodynamic of inecalcitol, a novel VDR agonist with docetaxel in metastatic castration-resistant prostate cancer patients (English)
1 reference
Jacques Medioni
1 reference
Gael Deplanque
1 reference
Jean-Marc Ferrero
1 reference
Tristan Maurina
1 reference
Jean-Michel P Rodier
1 reference
Eric Raymond
1 reference
Jorge Allyon
1 reference
Gerard Maruani
1 reference
Pascal Houillier
1 reference
Sarah Mackenzie
1 reference
Stephanie Renaux
1 reference
Jean-Francois Dufour-Lamartinie
1 reference
Reza Elaidi
1 reference
Celine Lerest
1 reference
Stephane Oudard
1 reference
10 July 2014
1 reference
1 reference
20
1 reference
17
1 reference
4471-4477
1 reference
Identifiers
1 reference
1 reference